Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis

被引：0
|
作者：
Li, Tingting [1 ,2 ,3 ]
Tao, Rong [4 ]
Yang, Li [1 ,2 ,3 ]
Wan, Zhe [1 ,2 ,3 ]
Li, Ruoyu [1 ,2 ,3 ]
Wang, Ruojun [1 ,2 ,3 ]
机构：
[1] Peking Univ First Hosp, Dept Dermatol, Beijing, Peoples R China
[2] Natl Clin Res Ctr Dermatol & Immunol Dis, Beijing, Peoples R China
[3] Peking Univ, Res Ctr Med Mycol, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tongren Hosp, Dept Dermatol, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2025年
关键词：
MGL-1304;
D O I：
10.1093/bjd/ljaf095
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Our study is the first to compare fungal microbiome changes in patients with atopic dermatitis (AD) before and after treatment with upadacitinib and dupilumab. We found that upadacitinib more effectively restores the fungal microbiome to levels observed in healthy individuals, which may contribute to its superior efficacy in head-and-neck dermatitis (a subtype of AD). The results enhance our understanding of how JAK inhibitors influence the skin microbiome in AD.
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dupilumab for the treatment of adolescents with atopic dermatitis
    Senner, Sonja
    Seegraber, Marlene
    Frey, Surina
    Kendziora, Benjamin
    Eicher, Laurie
    Wollenberg, Andreas
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (07) : 641 - 650
  • [42] Dupilumab: a milestone in the treatment of atopic dermatitis
    Tsianakas, Athanasios
    Staender, Sonja
    LANCET, 2016, 387 (10013): : 4 - 5
  • [43] Neutropenia on dupilumab in patients with atopic dermatitis
    Pathmarajah, Piru
    Corso, Roberto
    Salam, Amr
    Woolf, Richard
    Smith, Catherine
    Pink, Andrew
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 83 - 83
  • [44] Dupilumab for atopic dermatitis in metastatic cancer
    McClatchy, Jessica
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (05) : 472 - 475
  • [45] Abrocitinib versus dupilumab in atopic dermatitis
    Travers, Jared
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (05) : 1040 - 1040
  • [46] Remittive effect of Dupilumab in atopic dermatitis
    Treister, Alison D.
    Lio, Peter A.
    DERMATOLOGIC THERAPY, 2018, 31 (06)
  • [47] Dupilumab for atopic dermatitis: evidence to date
    Rodrigues, Maria A.
    Nogueira, Miguel
    Torres, Tiago
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2019, 154 (06): : 696 - 713
  • [48] Atopic Dermatitis: Therapy Option Dupilumab
    Bublak, Robert
    ALLERGO JOURNAL, 2014, 23 (07) : 12 - 12
  • [49] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [50] Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients
    Napolitano, Maddalena
    Ferrucci, Silvia Mariel
    Foggia, Luciano
    Hansel, Katharina
    Pezzolo, Elena
    Stingeni, Luca
    Antonelli, Elettra
    Picone, Vincenzo
    Patruno, Cataldo
    CLINICAL DRUG INVESTIGATION, 2024, 44 (01) : 71 - 77
12345